Skip to content

PROMUS Element™ Plus H7493911438400Recalls & reported problems

Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3

All models of PROMUS Element Plus (44)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08714729823773), received between Oct 20, 2017 and Oct 20, 2017 — classified as 1 injury.

The most frequently reported specific device problem is “Occlusion Within Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Occlusion Within Device1

Patient problems

  • Cardiac Enzyme Elevation1
  • Chest Pain1
  • Myocardial Infarction1
  • Occlusion1
  • Thrombosis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 20, 2017Occlusion Within Device; Occlusion Within Device

    IT WAS FURTHER REPORTED THAT STENT THROMBOSIS OF SVG TO OM2 OCCURRED.

    Patient problems: Cardiac Enzyme Elevation; Chest Pain; Myocardial Infarction; Occlusion; Thrombosis

    MAUDE report 6967349 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page